Over the past sixteen months, Chinese-domiciled biotechnology companies have solidified their position as pivotal players in the global pharmaceutical landscape,…
Read More
A decade in the making: How functional NAMs are redefining cardiac safety assessment
The rapid acceleration of New Approach Methodologies (NAMs) in drug safety testing has, for many, appeared to be a sudden…
Read More
BioNTech Pivots Dramatically to Oncology Amidst Waning Vaccine Revenue and Federal Shift, Cutting 1,860 Jobs and Investing €16.8 Billion in Cash
The German biotechnology powerhouse BioNTech, once synonymous with its groundbreaking COVID-19 vaccine, Comirnaty, is undergoing a profound strategic transformation, shedding…
Read More
Deloitte Report Reveals Pharma R&D Returns Surge to 7% Driven Primarily by GLP-1 Blockbusters, Raising Sustainability Concerns
A new report from Deloitte, titled "Navigating the GLP-1 boom," indicates a significant resurgence in biopharma R&D productivity, with the…
Read More
BD, Wellstar Connect Pharmacy-to-Bedside Medication Management with AI
BD, a global leader in medical technology, has announced a landmark partnership with Wellstar Health System, one of Georgia’s largest…
Read More
UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing
Researchers at UCLA have achieved a significant milestone in the arduous fight against glioblastoma, a notoriously aggressive and lethal form…
Read More
From list price to net price: How finance leaders decode real drug costs
In the complex tapestry of the healthcare industry, discussions surrounding drug pricing frequently commence and conclude with the list price.…
Read More
Lilly’s triple agonist achieves 16.8% weight loss in phase 3 trial
Eli Lilly and Company today announced groundbreaking results from a Phase 3 clinical trial for its investigational triple agonist, retatrutide,…
Read More
Small study suggests probiotic yogurt strain may boost immunotherapy response in lung cancer
The landscape of cancer treatment has been profoundly reshaped by immunotherapy, offering renewed hope and significantly improved prognoses for patients,…
Read More
Moving beyond the binary: how the convergence of small and large molecules is reshaping pharmaceutical R&D
Pharmaceutical R&D stands at a pivotal inflection point, witnessing a profound transformation in how diseases are targeted and treated. The…
Read More
